Cargando…
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
Prostate cancer (PC) is the most common type of tumor in men. In the early stage of the disease, it is sensitive to androgen deprivation therapy. In patients with metastatic castration-sensitive prostate cancer (mHSPC), chemotherapy and second-generation androgen receptor therapy have led to increas...
Autores principales: | Maselli, Felicia Maria, Giuliani, Francesco, Laface, Carmelo, Perrone, Martina, Melaccio, Assunta, De Santis, Pierluigi, Santoro, Anna Natalizia, Guarini, Chiara, Iaia, Maria Laura, Fedele, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297468/ https://www.ncbi.nlm.nih.gov/pubmed/37366915 http://dx.doi.org/10.3390/curroncol30060432 |
Ejemplares similares
-
The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions
por: Laface, Carmelo, et al.
Publicado: (2023) -
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
por: Laface, Carmelo, et al.
Publicado: (2023) -
The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies
por: Laface, Carmelo, et al.
Publicado: (2023) -
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
por: Laface, Carmelo, et al.
Publicado: (2023) -
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
por: Laface, Carmelo, et al.
Publicado: (2022)